Anja Bauerfeind

No ORCID on file · 4 papers in corpus
observational 2025
Population characteristics of intrauterine device users in real-world clinical practice across Europe - insights from the EURAS-LCS12 study
Contraception and reproductive medicine ·doi:10.1186/s40834-025-00353-8

BACKGROUND: The European Active Surveillance Study of LCS12 (EURAS-LCS12) investigates effectiveness and safety of intrauterine devices (IUDs) in routine clinical practice. Here, we aim to characterise the general population of IUD users ac…

other 2024
Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives
Obstetrics and gynecology ·doi:10.1097/aog.0000000000005509

This pooled analysis compared the risk of venous thromboembolism (VTE) associated with combined oral contraceptives (COCs) containing estradiol (E2) valerate-dienogest with those containing ethinyl E2-levonorgestrel. Data were retrieved fro…

2021
Thromboembolic safety profile of low-dose estradiol (valerate) in combined hormonal preparations: Implications for the development of new hormonal endometriosis and uterine fibroid therapies
·doi:10.1177/22840265211019546

Background: Several promising new medications containing low-dose estradiol (E2) in combination with a progestin and an additional component, such as gonadotropin-releasing hormone antagonists, are currently being developed for use in pre-m…

2020
ESTRADIOL IS ASSOCIATED WITH DECREASED CARDIOVASCULAR RISK COMPARED TO ETHINYLESTRADIOL WHEN CONTAINED IN COMBINED HORMONAL PREPARATIONS: IMPLICATIONS FOR THE DEVELOPMENT OF NEW ENDOMETRIOSIS THERAPIES
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.08.241